Effective humoral immunity against diphtheria and tetanus in patients with systemic lupus erythematosus or myasthenia gravis

Molecular Immunology

Volumn 54, Issue 3-4, 2013, Pages 453-456

  Csuka, Dorottya ^a   Czirják, László ^b   Hóbor, Renáta ^b   Illes, Zsolt ^c   Bánáti, Miklós ^c   Rajczy, Katalin ^d   Tordai, Attila ^d   Füst, George ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d Hungarian National Blood Transfusion Service   (Hungary)

Author keywords

Diphtheria; Myasthenia gravis; Systemic lupus erythematosus; Tetanus; Vaccine induced immune response

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; TETANUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIPHTHERIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PERTUSSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TETANUS; VACCINATION;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CASE-CONTROL STUDIES; DIPHTHERIA; DIPHTHERIA ANTITOXIN; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; TETANUS; TETANUS TOXOID;

EID: 84874359647     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.01.012     Document Type: Article

References (15)

1. Abe T., Homma M. Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses. Acta Rheumatologica Scandinavica 1971, 17(1):35-46.
2. Angelini C. Diagnosis and management of autoimmune myasthenia gravis. Clinical Drug Investigation 2011, 31(1):1-14.
3. Battafarano D.F., Battafarano N.J., et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis and Rheumatism 1998, 41(10):1828-1834.
4. Bijl M., Kallenberg C.G., et al. Vaccination of the immune-compromised patients with focus on patients with autoimmune-inflammatory diseases. The Netherlands Journal of Medicine 2011, 69(1):5-13.
5. Control, E. E. C. f. D. P. a., 2010. http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules/Pages/schedules.aspx.
6. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1997, 40(9):1725.
7. Kashef S., Ghazizadeh F., et al. Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid. Iran Journal of Immunology 2008, 5(3):181-184.
8. Marchand-Janssen C., Loulergue P., et al. Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses. Rheumatology (Oxford) 2011, 50(6):1099-1105.
9. Matouskova I., Matlerova S., et al. Persistence of antibodies against tetanus upon revaccination. Central European Journal of Public Health 2005, 13(2):99-102.
10. Meyer-Olson D., Witte T. Immunology: prevention of infections in patients with autoimmune diseases. Nature Reviews. Rheumatology 2011, 7(4):198-200.
11. Miyamoto M., Ono E., et al. Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus. Lupus 2011, 20(7):736-744.
12. Olander R.M., Auranen K., et al. High tetanus and diphtheria antitoxin concentrations in Finnish adults - time for new booster recommendations?. Vaccine 2009, 27(39):5295-5298.
13. Simonsen O., Kristiansen M., et al. Fall-off in immunity following diphtheria revaccination - an 8 year follow-up study. Acta Pathologica Microbiologica Scandinavica 1996, 104(12):921-925.
14. WHO, 2012. WHO and UNICEF estimates of immunization coverage: 2011 revision. http://www.who.int/immunization_monitoring/data/hun.pdf.
15. Zhang Q., Han F., et al. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. Journal of Infection 2011, 63(6):441-446.